Technology | November 14, 2007

FDA Clears Neurovascular Retriever for Use in Stroke Patients

Concentric Medical has obtained FDA 510(k) clearance for its Merci L6 Retriever, a device that restores blood flow to ischemic stroke patients. The Merci Retriever is designed to restore blood flow by engaging, capturing and removing blood clots. It is a shaped wire constructed of nitinol, a memory wire, which allows delivery of the Retriever in linear form using standard catheterization techniques. A small puncture in the groin is used to introduce the Merci Retriever into an artery leading to the brain. Upon reaching the targeted area, the Retriever returns to its original shape when deployed. The Merci L6 Retriever joins the L family of retrievers, incorporating a 2.7mm cylindrical helix with attached filaments. The filaments provide an additional mechanism for securing the clot during retrieval.


Related Content

News | Stroke

May 20, 2024 — Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the ...

Home May 20, 2024
Home
News | Stroke

May 16, 2024 — A new University of Cincinnati study provides more insight into how few patients have severe ischemic ...

Home May 16, 2024
Home
News | Stroke

May 7, 2024 — A new study by a global team of researchers, led by Sook-Lei Liew, PhD, of USC's Mark and Mary Stevens ...

Home May 07, 2024
Home
News | Stroke

March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke ...

Home March 05, 2024
Home
News | Stroke

March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 05, 2024
Home
News | Stroke

February 26, 2024 — Ischemic strokes are a major health burden. They occur when a blood vessel that supplies the brain ...

Home February 26, 2024
Home
News | Stroke

February 15, 2024 — Research findings in a clinical trial led by a professor at the University of Tennessee Health ...

Home February 15, 2024
Home
News | Stroke

February 13, 2024 — RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow ...

Home February 13, 2024
Home
News | Stroke

February 12, 2024 — VST Bio Corp. a leader in the development of innovative biologics to treat acute and chronic ...

Home February 12, 2024
Home
News | Stroke

February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective ...

Home February 09, 2024
Home
Subscribe Now